A B S T R A C T The relationship between group B streptococcal (GBS) type-specific antisera and the type II-specific polysaccharide is evaluated from a structural and immunologic viewpoint. Although all GBS type-specific polysaccharides are composed of the same monosaccharides, the type II antigen is more complex structurally and contains these sugars in a molar ratio different from the other antigens. Type II polysaccharide has two side chains. One contains only sialic acid and is less susceptible to acid cleavage than sialic acid residues found on types III, Ia, and Ib polysaccharides. The other side chain is composed of galactose as the only sugar. Immunochemical studies demonstrate that the type II polysaccharide has several immunodeterminants. One of these determinants is likely to be the side-chain galactose, while sialic acid appears to comprise part of another immunodeterminant, more complex than sialic acid alone. A series of cross-reactions is demonstrated between the type II native antigen and antisera to serotypes Ia, III, and Ib by a sensitive radioactive antigen-binding assay, which account for additional, complex immunodeterminants. The strongest of these cross-reactions is with type Ia antiserum and the weakest with lb antiserum. Since Ia and lb polysaccharides differ in only one linkage, these findings suggest that the trisaccharide BD- 
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INTRODUCTION
For more than a decade, group B streptococci (GBS)' have been a leading cause of neonatal sepsis in the United States (1) . Among the five serotypes of group B streptococci, type II strains, which account for -15% of all infant infections, have been isolated only rarely from infants with meningitis (2, 3) . Among GBS isolates from adults with meningitis, however, type II strains predominate (3) .
Antibodies directed against the type II capsular polysaccharide have been shown to be protective in mice challenged with homologous organisms and to be bactericidal with polymorphonuclear leukocytes and complement in an opsonophagocytic assay (4, 5) . In addition, opsonic antibody to type II organisms has been reported to be absent in the sera of mothers and neonates who subsequently develop type II infection (6) .
A structure has been proposed by Jennings et al. (7) for the native type II GBS polysaccharide. Like the other type-specific GBS polysaccharides, the type II antigen is composed of a repeating unit of five monosaccharides. The molar ratio of these sugars differs in the type II polysaccharide from the others. The structure also is more complex. The repeating unit of this polysaccharide is represented in Fig. 1 . The type II antigen has two side chains, each a monosaccharide, in contrast to the other type-specific polysaccharides that have one side chain composed of several sugars. Sialic acid directly attaches to the backbone of the type II antigen.
Preliminary immunochemical studies of the type II polysaccharide performed by Lancefield (8) and Freimer (9) indicated that this antigen had an acid labile determinant that was part of a more complete immunodeterminant. The present study was (10) . Unabsorbed antisera were utilized for further definition of cross-reacting antigenic determinants, although the standard procedure for preparation of types Ia-and Ib-specific antisera involves absorption with the alternate bacterial strain (11, 12) . The sera used in these latter studies were prepared with formalin-fixed organisms grown under conditions of neutral pH (13, 14) .
Antigen preparation. Native (containing sialic acid) and core (lacking sialic acid) polysaccharides of type II GBS were extracted and purified by methods described for the type Ia and III polysaccharides (7, (13) (14) (15) . Carbohydrate composition and structural analysis of the type Ia (14, 15) , Ib (15) , and III (13, 16) polysaccharides are described in detail elsewhere and summarized in Fig. 1 . These antigens contain no detectable protein or nucleic acid. Furthermore, by gas-liquid chromatography no rhamnose, an indicator monosaccharide for contamination with group-specific antigen, was found in any preparation. Type Ia, lb, and III native and core antigens were extracted and characterized as previously described (13) (14) (15) (16) .
Chemical modification of polysaccharides. The backbone of the type III antigen used in inhibition studies was prepared by the removal of the terminal l#D-galactopyranosyl residues from the type III core antigen as previously described (16) . In this procedure the primary hydroxyl groups of the terminal #D-galactopyranosyl residues were oxidized selectively with galactose oxidase to aldehyde groups. Following basic elimination, these terminal residues were removed by short treatment with mild acid.
The degalactosylated type Ia and lb antigens (performed after removal of sialic acid) previously shown to be identical structurally (15) , were prepared by the controlled periodate oxidation of their respective core antigens (15) . In this reaction the terminal lSD-galactopyranosyl residues were oxidized selectively, and the remnants of these residues removed by reduction and mild acid treatment of the oxidized core antigens. The common backbone of the type Ia and lb antigens were prepared by deamination of the N-deacetylated type Ia or Ib core antigens (15) . Accomplishment of all these structural modifications was confirmed by methylation analysis and '3C nuclear magnetic resonance spectroscopy (15, 16) . The structures of these modified antigens are shown in Fig. 1 (18) . Therefore, this constant can be used for comparative estimates of molecular size of polysaccharides (19) .
Serological methods. Capillary precipitin tests were performed by the method of Lancefield (11, 12) . Double diffusion in agar was prepared as described by Ouchterlony (20) . Immunoelectrophoresis was performed by the method of Scheidegger (21) under conditions previously published for the type III polysaccharide (22) .
Antibodies to the type Ia and III polysaccharides in sera from human volunteers were quantified by a radioactive antigen-binding assay (RABA) (23, 24 Quantitative precipitin and quantitative precipitin inhibition studies were conducted as previously described (22 (25, 26) were tested for the development of antibodies cross-reactive with the native type II polysaccharide. Sera were stored at -70°C before testing.
The geometric mean antibody concentration and 95% confidence intervals were calculated for each group of subjects (26) . Differences in concentrations of antibody in pre-and postimmunization sera of individuals were determined by the paired t test (27) . II antiserum. 1 ml of type II antiserum was absorbed at equivalence with native type II antigen first at 25°C for 2 h and then at 4°C for 48 h. After removal of the precipitate by centrifugation, varying amounts of core antigen were added to 50-,ug aliquots of the absorbed type II antiserum. After absorption, most of the antibodies that had reacted with the core antigen in unabsorbed type II antiserum had been eliminated (Fig.  4) . However, in the converse experiment, after absorption of type II antiserum with an equivalence concentration of core antigen, a substantial quantity of antibody remained in the serum that could be precipitated with the native type II polysaccharide (Fig. 4) . These data were consistent with the results of double diffusion in agar experiments (Fig. 2) A series of monosaccharide-inhibition studies was conducted to search for an immunodominant monosaccharide (Fig. 5) . Galactose inhibited a maximum of 50% of the antibodies that precipitated with either the core or native antigen, but this degree of inhibition required a large excess of galactose (>1,000-fold) compared with the quantity of precipitating polysaccharide. This monosaccharide seemed unlikely to constitute a high-affinity immunodeterminant. The inhibition reaction by galactose was specific and dose related, however, while other monosaccharides failed to inhibit even at high concentrations.
RESULTS

Molecular
A "pseudoinhibition" was observed when sialic acid was used as the inhibiting monosaccharide for precipitation with type II antiserum of either the native or core polysaccharide. The acidic nature of sialic acid caused the pH of inhibition tubes containing this sugar (2-20 mg) to fall to 3.5. When the pH was raised to 7.6 with 0.01 N NaOH, inhibition by sialic acid did not occur (Fig. 5a and b) .
Multiple cross-reactive antibodies in group B streptococcal type-specific antisera. The RABA provided a highly sensitive tool to determine the presence of antibodies directed to the native type II polysaccharide in unabsorbed rabbit sera raised to each of the type- FIGURE 3 Immunoelectrophoresis of native type II group B streptococcal antigen (lower well) and core type II antigen (upper well) vs. type II group B streptococcal antiserum (trough). specific strains grown under conditions of neutral pH. Structural similarities of several sites on these related polysaccharides led to the hypothesis that cross-reactions would exist. Although these heterologous sera did not give capillary precipitin reactions with type II native antigen, all contained some cross-reacting antibodies that were detected by the more sensitive RABA (Table 1) . These cross-reactions were not due to contamination of the type II antigen with group polysaccharide because the type II antigen did not react with group B-specific serum and did not contain rhamnose by chemical analysis. The latter sugar has been shown to constitute a major component of the group B, as opposed to type specific, polysaccharide (17) .
Clarification of the nature of the cross-reactive determinants required RABA inhibition with specific antigens (Table II (26) , the data were analyzed with this variable in mind. Of the 13 vaccinees with levels of antibody to the type II antigen of <2 qg/ml in preimmunization sera, 12 (92%) responded with a >1.0 ug/ml increase in antibody 4 wk later, and the geometric mean concentration of antibody in their sera increased from 1.3 to 10.2 ,g/ml (t = 3.8, P < 0.01; paired t test). Of the seven subjects with >2 sg/ml of type II antibody in preimmunization serum, each responded to immunization with a >1 gg/ml increase at 4 wk, and the geometric mean antibody in sera from 
DISCUSSION
The continuing prominence of the group B Streptococcus as a cause of neonatal morbidity and mortality has prompted investigative efforts aimed at prevention of infection due to this bacterium. Since susceptibility to invasive infection in mice (4) and in human infants (6, 23, 24) correlates with low levels of serum antibody directed against the type-specific antigens of GBS, one proposed method for the prevention of neonatal disease is active immunization of child-bearing age women with these polysaccharides. This method presumes immunogenicity and safety of candidate vaccines, induction of IgG class antibody to insure placental transport, and protection by these maternally derived antibodies in neonates susceptible to invasive infection. For type III GBS the first two requirements have been experimentally verified (24, 25) , although protective efficacy remains to be documented. Although little is known about human immunity to other serotypes of GBS, careful immunologic and chemical characterization of their surface antigens has served as a major approach to vaccine development. Precise knowledge of the structures of specific polysaccharides can allow more definitive identification of their immunodeterminants and insights into the basis of serological cross-reactions involving these antigens. We have explored the structural and immunologic relationships between group B streptococcal antisera and the type II-specific polysaccharide. Jennings et al. (7) have defined structurally the type II native and core polysaccharides. These polysaccharides contain the same monosaccharides found in the type Ia, Ib, and III GBS polysaccharides but in different molar ratios (Fig. 1) . The type III polysaccharide has a single galactose-sialic acid side chain protruding from a trisaccharide backbone, while the type la and Ib polysaccharides have disaccharide backbones that are identical. These latter two polysaccharides have similar monosaccharides in their trisaccharide side chain, and their structures differ only in the linkage of galactose to the glucosamine of the side chain.
Earlier studies defined two distinct populations of mouse protective type-specific antibodies directed against different determinants on the capsule of type II GBS organisms (8, 9) . Antibodies to these determinants were equally protective. One antibody population was directed against an HCI-extracted antigen, which contained galactose, glucose, and glucosamine. Another population of protective antibodies was directed to an acid labile determinant, present on an antigen extracted with cold trichloracetic acid (TCA). This work is the basis for our current understanding of antibody specificity to this GBS serotype.
It is clear now from our structural studies that the acid labile structural determinant described by Lancefield and Freimer was sialic acid; and chemically the cold TCA-extracted type II antigen has enough of this sialic acid remaining to be equivalent antigenically to the native type II polysaccharide.
By precipitation inhibition studies, Freimer (9) found that the monosaccharide, D-galactose, was a specific determinant of the core antigen. We have corroborated his observations and believe that the galactose which was immunodominant is likely to be the side-chain galactose. Galactose is capable of inhibiting a population of the antibodies in type II serum precipitating both the native and core polysaccharides. This finding suggested that this galactose determinant was exposed on both antigens. The requirement for a large excess of galactose for inhibition compared with the amount of precipitating polysaccharide suggested that, although galactose is an inhibitor, the complete immunodeterminant may well be larger than the terminal galactopyranose residue alone.
As with other type-specific polysaccharides (Ta and III), sialic acid appeared to be involved in a native more complete immunodeterminant as indicated by the partial identity (Fig. 2) . Although there was a population of antibodies in type II GBS antiserum that was specific for the native determinant, this determinant was not sialic acid alone. "Pseudoinhibition," dependent on pH, was seen by sialic acid in the studies of quantitative precipitation (Fig. 5) . Previously, investigators have described sialic acid as an immunodominant sugar of group B streptococcal polysaccharides (28, 29) . Using neutral conditions, we never have found that sialic acid functions as an independent immunodeterminant. Perhaps this discrepancy is explicable by the pH-dependent phenomenon. Even if sialic acid were part of a determinant on the polysaccharides, it would be unlikely that free sialic acid would be a good inhibitor. Free sialic acid exists preponderantly as the #3D-anomer in solution (30) , whereas the terminal sialic acid residues of the native GBS polysaccharides are in the opposite aD-configuration (7, (13) (14) (15) (16) .
A series of interesting cross-reactions was described between the type II The other possibility was that this immunodeterminant was also conformationally dependent.
These cross-reactions were not due to contamination by the group B antigen, because (a) that polysaccharide fails to inhibit any cross-reactions; (b) there is no rhamnose in these capsular polysaccharides (rhamnose was immunodominant on the group B polysaccharide); and (c) the type II native antigen fails to react with group B-specific antiserum as measured by the sensitive RABA.
It is interesting that Freimer (9) The native type II polysaccharide given to human volunteers was of large molecular size and was nontoxic in laboratory animals. In the 20 immunized human volunteers, no systemic reactions were observed and local reactions were mild, transient, and infrequent (15%). 19 (95%) responded with >1.0 g/ml increases in specific serum antibody. The response rate to immunization with type II polysaccharide in those individuals who had low preimmunization antibody levels (92%) was greater than that reported in adults with low levels of antibody to type III polysaccharide before immunization with that vaccine (73%) (25) . As has been reported for other polysaccharides, antibody levels persisted for at least 2 yr.
The high response rate to this polysaccharide, coupled with the observed cross-reactions between the type-specific polysaccharides and the type II antigen in rabbit antisera suggested the possibility of detecting rises in antibody to other type-specific polysaccharides in humans after immunization with the type II antigen. This hypothesis was attractive particularly because lower response rates have been observed in adults immunized with the Ia or III polysaccharides. 2 Unfortunately, cross-reactions similar to those found in rabbit antisera were not observed in humans after immunization with the purified type II polysaccharide.
Although cross-reactions are attributable to determinants existing on the polysaccharides, it is possible that these determinants were not sufficiently immunogenic to induce cross-reactive antibodies in adults given a single dose of type II polysaccharide.
